DCF — LINCOLNHEALTH
Enterprise Value: $-37.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-37.1M
Enterprise Value
$-15.0M
PV of Cash Flows
$-22.1M
PV of Terminal Value
$-35.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $120.3M | $-0.5M | -0.0% | $-5.6M | $-5.1M |
| Year 2 | $123.9M | $0.7M | 1.0% | $-4.6M | $-3.8M |
| Year 3 | $127.7M | $2.0M | 2.0% | $-3.4M | $-2.6M |
| Year 4 | $131.5M | $2.7M | 2.0% | $-2.9M | $-2.0M |
| Year 5 | $135.4M | $3.1M | 2.0% | $-2.6M | $-1.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-37.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$116.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.009420515838937667
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5